Lea M. Johnson

435 total citations
7 papers, 277 citations indexed

About

Lea M. Johnson is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Lea M. Johnson has authored 7 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Lea M. Johnson's work include Protein Kinase Regulation and GTPase Signaling (5 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Peptidase Inhibition and Analysis (3 papers). Lea M. Johnson is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Peptidase Inhibition and Analysis (3 papers). Lea M. Johnson collaborates with scholars based in United States and United Kingdom. Lea M. Johnson's co-authors include David W. Snyder, Nicholas J. Bach, Robert D. Dillard, Susan E. Draheim, Lawrence W. Hartley, Amy C. Smith, Jean‐Pierre Wery, Emma R. McKinney, Noel D. Jones and Richard W. Schevitz and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Lea M. Johnson

7 papers receiving 266 citations

Peers

Lea M. Johnson

MB

OC

GENET

PHARM

CR

Afshin Bahador United States

Louis Locco United States

Tania Tahtouh France

Katherine L. Lee United States

Yuki Nagano Japan

Jake Ni United States

Yumi Matsui Japan

Koc-Kan Ho United States

Thomas J. McLellan United States

Hiroki Umemiya Japan

Afshin Bahador United States

Lea M. Johnson

314 ×1.8

MB

47 ×0.7

OC

33 ×0.8

GENET

33 ×1.0

PHARM

21 ×0.7

CR

Citations per year, relative to Lea M. Johnson Lea M. Johnson (= 1×) peers Afshin Bahador

Countries citing papers authored by Lea M. Johnson

Since Specialization

Citations

This map shows the geographic impact of Lea M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea M. Johnson more than expected).

Fields of papers citing papers by Lea M. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea M. Johnson. The network helps show where Lea M. Johnson may publish in the future.

Co-authorship network of co-authors of Lea M. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Lea M. Johnson. A scholar is included among the top collaborators of Lea M. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea M. Johnson. Lea M. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Masters, John J., Valentine J. Klimkowski, Michael Chouinard, et al.. (2007). Investigation of the terminal P4 domain in a series of d-phenylglycinamide-based factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(24). 6910–6913. 1 indexed citations

2.

Snyder, David W., Nicholas J. Bach, Robert D. Dillard, et al.. (1999). Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI. Journal of Pharmacology and Experimental Therapeutics. 288(3). 1117–1124. 70 indexed citations

3.

Chang, Ying-Fon, D O'Connell, Stanley C. Gill, et al.. (1998). High-Affinity Aptamers Selectively Inhibit Human Nonpancreatic Secretory Phospholipase A₂ (hnps-PLA₂). Journal of Medicinal Chemistry. 41(6). 778–786. 28 indexed citations

4.

Draheim, Susan E., Nicholas J. Bach, Robert D. Dillard, et al.. (1997). ChemInform Abstract: Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. Part 3. Indole‐3‐glyoxamides.. ChemInform. 28(16). 3 indexed citations

5.

Draheim, Susan E., Nicholas J. Bach, Robert D. Dillard, et al.. (1996). Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 3. Indole-3-glyoxamides. Journal of Medicinal Chemistry. 39(26). 5159–5175. 76 indexed citations

6.

Dillard, Robert D., Nicholas J. Bach, Susan E. Draheim, et al.. (1996). Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 1. Indole-3-acetamides. Journal of Medicinal Chemistry. 39(26). 5119–5136. 64 indexed citations

7.

Dillard, Robert D., Nicholas J. Bach, Susan E. Draheim, et al.. (1996). Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 2. Indole-3-acetamides with Additional Functionality. Journal of Medicinal Chemistry. 39(26). 5137–5158. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact